ARTICLE | Clinical News
HEV vaccine meets endpoint
August 24, 2010 12:31 AM UTC
Researchers from Xiamen University and colleagues reported that intramuscular injections of HEV 239 at months 0, 1 and 6 met the primary endpoint of a significantly lower rate of hepatitis E virus (HE...